Development of encapsulation materials and design for implantable 3D bioprinted pancreatic cells

点击翻译按钮获取中文摘要

Emerging cellular therapies have the potential to both greatly improve the health of individuals and to reduce healthcare costs with improved treatments for injuries or curing diseases. For example, it has been established that a cellular transplant therapy can reverse and potentially cure type 1 diabetes. However, the development of reliable and economical means of mammalian cell manufacturing and delivery of these therapies is essential to ensure that many promising emerging health care technologies become widely available to the patients who need them. Thus, the great promise of these emerging treatments comes with great challenges, many of those in the field of cell culture process and device engineering that this project addresses. Ultimately, increased access to safe and affordable cell culture products will improve the quality of many thousands of Canadian lives. UBC and Canadian multidisciplinary groups are among the leaders in this area of research. Exporting these technologies and knowledge should benefit populations around the world as well as translate into substantial commercial benefits for Canadians.